Lumen Technologies’ ( LUMN ) stock fell almost 9% even though the company beat Q3 expectations . They reported non-GAAP EPS of -$0.20, which was a$0.07 beat, and revenue of $3.09 billion, about$50 million above estimates. The stock slide was drivenI hold a Master’s degree in Cell Biology and began my career working for several years as a lab technician in a drug discovery clinic, where I gained extensive hands-on experience in cell culture, assay development, and therapeutic research. That scientific foun ...